Arvinas (ARVN) EBIT Margin Growth (3y) (2020 - 2026)
Powered by 
Analysis
Arvinas (ARVN) EBIT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -2,649.00 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 30,461.00 |
| 10 | Arvinas | 609.44 Mn | 41.54 Mn | - | 20,260.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,260.00 |
| Mar 31, 2026 | -13,913.00 |
| Dec 31, 2025 | -58,526.00 |
| Sep 30, 2025 | 8,914.00 |
| Jun 30, 2025 | -12,452.00 |
| Mar 31, 2025 | 25,555.00 |
| Dec 31, 2024 | 4,476.00 |
| Sep 30, 2024 | 44,972.00 |
| Jun 30, 2024 | 88,024.00 |
| Mar 31, 2024 | 42,893.00 |
| Dec 31, 2023 | 100,348.00 |
| Sep 30, 2023 | 20,433.00 |
| Jun 30, 2023 | 32,389.00 |
| Mar 31, 2023 | 10,537.00 |
| Dec 31, 2022 | 26,574.00 |
| Sep 30, 2022 | -21,199.00 |
| Jun 30, 2022 | 26,406.00 |
| Mar 31, 2022 | 17,600.00 |
| Dec 31, 2021 | 34,945.00 |
| Sep 30, 2021 | -9,208.00 |